...
首页> 外文期刊>PLoS One >β-Sitosterol 3- O -D-glucoside increases ceramide levels in the stratum corneum via the up-regulated expression of ceramide synthase-3 and glucosylceramide synthase in a reconstructed human epidermal keratinization model
【24h】

β-Sitosterol 3- O -D-glucoside increases ceramide levels in the stratum corneum via the up-regulated expression of ceramide synthase-3 and glucosylceramide synthase in a reconstructed human epidermal keratinization model

机译:β-谷甾醇3-O -D-葡萄糖苷通过在重建的人表皮角质化模型中通过神经酰胺合酶-3和葡萄糖酰胺合成酶的上调表达增加了地层中的神经酰胺水平

获取原文
           

摘要

β-Sitosterol 3- O - d -glucoside (BSG) is known to act as an agonist by binding to estrogen receptors, and estrogen has been reported to enhance the activity of β-glucocerebrosidase, an epidermal ceramide metabolizing enzyme. In this study, we determined whether BSG up-regulates ceramide levels in the stratum corneum (SC) of a reconstructed human epidermal keratinization (RHEK) model. Treatment with BSG significantly increased the total ceramide content by 1.2-fold compared to that in the control in the SC of the RHEK model, accompanied by a significant increase of the ceramide species, Cer[EOS] by 2.1-fold compared to that in the control. RT-PCR analysis demonstrated that BSG significantly up-regulated the mRNA expression levels of serine palmitoyltransferase (SPT)2, ceramide synthase (CerS)3, glucosylceramide synthase (GCS) and acid sphingomyelinase by 1.41–1.89, 1.35–1.44, 1.19 and 2.06-fold, respectively, compared to that in the control in the RHEK model. Meanwhile, BSG significantly down-regulated the mRNA expression levels of sphingomyelin synthase (SMS)2 by 0.87–0.89-fold. RT-PCR analysis also demonstrated that BSG significantly up-regulated the mRNA expression levels of CerS3 and GCS by 1.19–1.55 and 1.20-fold, respectively, but not of SPT2 and significantly down-regulated that of SMS2 by 0.74-fold in HaCaT keratinocytes. Western blotting analysis revealed that BSG significantly increased the protein expression levels of CerS3 and GCS by 1.78 and 1.28–1.32-fold, respectively, compared to that in the control in HaCaT cells. These findings indicate that BSG stimulates ceramide synthesis via the up-regulated expression levels of CerS3 and GCS in the glucosylceramide pathway, which results in a significantly increased level of total ceramides in the SC accompanied by significantly increased levels of acylceramide species such as Cer[EOS].
机译:已知β-谷胱甘肽3-O-D-葡糖苷(BSG)通过与雌激素受体结合而作为激动剂,并且据报道雌激素增强β-葡聚糖酯酶的活性,表皮神经酰胺代谢酶。在这项研究中,我们确定了BSG上调节了重建人表皮角质化(RHEK)模型的角质层(SC)中的神经酰胺水平。与该控制在RHEK模型SC的控制中,BSG的治疗显着增加1.2倍,伴随着锡酰胺种类的显着增加,CER [EOS]比相比下降了2.1倍控制。 RT-PCR分析证明,BSG显着上调丝氨酸棕榈酰转移酶(SPT)2的mRNA表达水平,神经酰胺合酶(CERS)3,葡萄糖酰胺合酶(GCS)和酸鞘氨基酶酶1.41-1.89,1.35-1.44,1.19和2.06 - 与Rhek模型中的控制相比,分别为零。同时,BSG显着下调鞘磷脂合成酶(SMS)2的mRNA表达水平0.87-0.89倍。 RT-PCR分析还证明,BSG分别将CERS3和GCS的mRNA表达水平显着上调为1.19-1.55和1.20倍,但不是SPT2,并且在HACAT角蛋白细胞中显着下调SMS2的SMS2的下调0.74倍。 Western印迹分析显示,与HACAT细胞中的对照相比,BSG分别将CERS3和GCS的蛋白质表达水平显着增加1.78和1.28-1.32倍。这些发现表明,BSG通过葡萄糖胺途径中的CER3和GCS的上调表达水平刺激神经酰胺合成,这导致SC中总神经酰胺水平显着增加,伴随着CER [EOS等酰基胺种类水平的显着增加。 ]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号